BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 18711818)

  • 1. [Daily thrombocyte count in low molecular weight heparin treatment].
    Spannagl M
    Chirurg; 2008 Mar; Suppl():85. PubMed ID: 18711818
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin-induced thrombocytopenia and thrombosis with spinal ischemia--recovery of platelet count following change to low molecular weight heparin].
    Maurin N; Biniek R; Bohndorf K; Heintz B; Kierdorf H; Schulte-Bockholt A
    Vasa Suppl; 1991; 32():295-9. PubMed ID: 1663274
    [No Abstract]   [Full Text] [Related]  

  • 3. [Heparin-associated thrombocytopenia caused by low-molecular-weight heparin].
    Köninger J; Greinacher A; Müller-Beissenhirtz W; Strosche H
    Unfallchirurg; 1995 Jan; 98(1):49-51. PubMed ID: 7886465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-induced thrombocytopenia after liver transplantation.
    Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Makuuchi M
    Transplant Proc; 2008 Jun; 40(5):1518-21. PubMed ID: 18589141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Heparin-induced thrombocytopenia and thrombosis with spinal ischemia].
    Maurin N; Biniek R; Bohndorf K; Heintz B; Kierdorf H; Schulte-Bockholt A
    Internist (Berl); 1991 Jul; 32(7):431-4. PubMed ID: 1657813
    [No Abstract]   [Full Text] [Related]  

  • 6. Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT).
    Rota E; Bazzan M; Fantino G
    Thromb Haemost; 2008 Apr; 99(4):779-81. PubMed ID: 18392338
    [No Abstract]   [Full Text] [Related]  

  • 7. [Heparin-associated thrombocytopenia, thrombosis and embolism. Side effects of thromboembolism prevention with low molecular weight heparin enoxaparin?].
    Mohr VD; Lenz J
    Chirurg; 1991 Sep; 62(9):686-90. PubMed ID: 1660803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thrombocytopenia can be HIT. Heparin treatment can cause low life-threatening thrombocyte levels].
    Själander A; Johansson L; Hillarp A; Bergqvist D; Tengborn L; Svensson P
    Lakartidningen; 2009 Mar 4-10; 106(10):682-5. PubMed ID: 19418688
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current aspects of perioperative heparin administration].
    Basic-Micic M; Breddin HK
    Gynakologe; 1991 Feb; 24(1):59-63. PubMed ID: 1646144
    [No Abstract]   [Full Text] [Related]  

  • 10. Low molecular weight heparin-induced thrombocytopenia and thrombosis.
    Peters FP; Doevendans PA; Erdkamp FL; Van Der Ent FW; De Heer F
    Eur J Haematol; 1996 May; 56(5):329-30. PubMed ID: 8641411
    [No Abstract]   [Full Text] [Related]  

  • 11. [Low molecular heparin in the prophylaxis of postoperative thrombosis].
    Suomalainen O
    Duodecim; 1996; 112(17):1545-51. PubMed ID: 10596143
    [No Abstract]   [Full Text] [Related]  

  • 12. Heparin-induced thrombocytopenia with thrombotic complications during prophylactic treatment with low-molecular-weight heparin.
    de Raucourt E; Vinsonneau C; Juvin K; Fischer AM; Meyer G
    Blood Coagul Fibrinolysis; 1996 Nov; 7(8):786-8. PubMed ID: 9034559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can thrombosis be prevented through immediate postoperative low-molecular-weight-heparin prophylaxis?].
    Bank I; Büller HR
    Ned Tijdschr Geneeskd; 2000 Oct; 144(42):2031. PubMed ID: 11072524
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of unfractionated heparin and long-term treatment with low-molecular-weight heparin, bemiparin, on potassium levels.
    Rocha E; Gómez-Outes A; Martínez González J; Kakkar VV
    Thromb Haemost; 2005 Nov; 94(5):1109-10. PubMed ID: 16363259
    [No Abstract]   [Full Text] [Related]  

  • 15. Dose-finding studies of reviparin in elective hip surgery.
    Planès A; Vochelle N; Chevret S; Fagola M; Bellaud M
    Semin Thromb Hemost; 1993; 19 Suppl 1():44-8. PubMed ID: 8395731
    [No Abstract]   [Full Text] [Related]  

  • 16. Low-molecular-weight heparin and thrombocytosis: a further reason to monitor the platelet count.
    Prescrire Int; 2003 Oct; 12(67):183. PubMed ID: 14619899
    [No Abstract]   [Full Text] [Related]  

  • 17. [Heparin-induced thrombocytopenia. How can the risk of postoperative thrombosis or pulmonary embolism be reduced?].
    Greinacher A
    Orthopade; 1996 Aug; 25(4):379-84. PubMed ID: 8927386
    [No Abstract]   [Full Text] [Related]  

  • 18. Delayed hypersensitivity challenged by subcutaneous Bemiparin.
    Moreno Escobosa MC; Moya Quesada MC; Granados SC; Amat López J
    Allergol Immunopathol (Madr); 2011; 39(5):309-10. PubMed ID: 21129837
    [No Abstract]   [Full Text] [Related]  

  • 19. [When long-term marcumar administration is needed. Low-molecular-weight heparin bridges the surgery gap].
    MMW Fortschr Med; 2001 Feb; 143(8):52. PubMed ID: 11265545
    [No Abstract]   [Full Text] [Related]  

  • 20. A benchmark for platelet count monitoring with low-molecular-weight heparin: expanding implementation of National Patient Safety Goals.
    Spinler SA
    Ann Pharmacother; 2009 Sep; 43(9):1519-21. PubMed ID: 19690223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.